ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.63
-1.01%
Dow Jones
37,949.24
-1.14%
US Dollar vs MXN
17.12136
0.63%
Brent Oil
86.105
-1.35%
Bitcoin
60,011.64
-5.99%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gilead Sciences Inc (GILD)

  7. Gilead Sciences Inc (GILD) Noticias

GILD Gilead Sciences Inc

65.065
-0.875 (-1.33%)
Última actualización: 14:19:19
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Gilead Sciences Inc GILD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.875 -1.33% 65.065 14:19:19
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
65.62 64.89 65.60 65.94
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202407:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/4/202406:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/4/202415:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/4/202406:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/4/202415:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/3/202407:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/3/202406:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22/3/202408:18BWGilead Sciences Announces Completion of Acquisition of..
18/3/202418:29BWCenter for Disease Analysis Foundation Announces First Round..
11/3/202407:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/3/202407:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/3/202415:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/3/202409:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/3/202407:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202415:35BWNew Real-World Data Further Support the Use of Veklury®..
05/3/202415:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
29/2/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:49EDGAR2Form 144 - Report of proposed sale of securities
28/2/202415:38EDGAR2Form 144 - Report of proposed sale of securities
27/2/202409:00BWGilead Announces Funding Initiative to Support HIV..
26/2/202415:05BWU.S. FDA Approves Expanded Indication for Gilead’s Biktarvy®..
26/2/202407:30BWGilead to Present Late-Breaking Data and Real-World Evidence..
23/2/202405:09EDGAR2Form SC TO-T - Tender offer statement by Third Party
20/2/202415:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/2/202415:05BWGilead Sciences to Present at Upcoming Investor Conferences
14/2/202416:08EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/2/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:14EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202407:39EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202407:37EDGAR2Form 8-K - Current report
09/2/202417:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202410:00BWGilead Named One of America’s Most JUST Companies by JUST..
07/2/202416:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/2/202404:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
06/2/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202415:05BWGilead Sciences Announces 2.7 Percent Increase in First..
06/2/202415:04EDGAR2Form 8-K - Current report
06/2/202415:02BWGilead Sciences Announces Fourth Quarter and Full Year 2023..
06/2/202405:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
02/2/202415:20EDGAR2Form 8-K - Current report
02/2/202413:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202413:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202413:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202413:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:31BWTed Love, MD, Joins Gilead Sciences’ Board of Directors
31/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados